Bionomics Ltd. (BNOEF) 0.3700 $BNOEF Bionomics Initiates

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bionomics Ltd. (BNOEF) 0.3700 $BNOEF

Bionomics Initiates Phase II Clinical Trial of BNC210 for Treatment of Anxiety
PR Newswire - Mon Apr 20, 5:00AM CDT
Bionomics Limited (ASX: BNO, OTCQX: BNOEF) , a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of cancer and diseases of the central nervous system, today announced the initiation of a Phase II clinical study of BNC210, the Company's drug candidate in development for the treatment of anxiety and depression.
BNO: 23.85 (-0.22)

Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting
PR Newswire - Fri Apr 17, 5:00AM CDT
Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of cancer and diseases of the central nervous system, today announced the presentation of data from three of its most advanced oncology programs at the upcoming American Association for Cancer Research (AACR) 106th Annual Meeting being held from April 18-22, 2015 in Philadelphia, PA USA.
BNO: 23.85 (-0.22)

BNC105 Biomarker Data to Be Presented at Asian Oncology Conference
PR Newswire - Fri Apr 10, 5:00AM CDT
Bionomics Limited (ASX: BNO, OTCQX: BNOEF) today announced that it will present a poster with new data on the DisrupTOR-1 trial of BNC105 in patients with metastatic renal cancer at the 7th Asian Oncology Summit being held from April 10-12, 2015 in Shanghai, China.
BNO: 23.85 (-0.22)

Chronic Pain Therapeutics Pipeline Review 2015 - 62 Companies & 138 Drug Profiles
M2 - Wed Mar 11, 6:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/98dtzm/chronic_pain) has announced the addition of the "Chronic Pain - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Chronic Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Pain and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AbbVie Inc. - Acadia Pharmaceuticals Inc. - Adynxx, Inc. - Akron Molecules AG - Allergan, Inc. - arGEN-X BV - Astellas Pharma Inc. - Astraea Therapeutics, LLC - AstraZeneca PLC - BCN Peptides, S.A. - BioDelivery Sciences International, Inc. - Bionomics Limited - Cara Therapeutics, Inc. - ChironWells GmbH - Chromocell Corporation - Collegium Pharmaceutical, Inc. - CoLucid Pharmaceuticals, Inc. - Convergence Pharmaceuticals Ltd. - Creabilis SA - Cytogel Pharma, LLC - Daewoong Pharmaceutical Co., Ltd. - Daiichi Sankyo Company, Limited - Dompe Farmaceutici S.p.A. - DURECT Corporation - Egalet Corporation - Eli Lilly and Company - Endo Pharmaceuticals Inc. - Glenmark Pharmaceuticals Ltd. - Grunenthal GmbH - Johnson & Johnson For more information visit http://www.researchandmarkets.com/research/98...ronic_pain
BDSI: 8.43 (-0.34), ENDP: 82.67 (-2.68), LLY: 72.81 (-0.09), DRRX: 2.43 (+0.08), AGN: 240.22 (+2.88), JNJ: 103.17 (+0.87), ACAD: 40.29 (+1.12), EGLT: 9.22 (-0.17), AZN: 68.92 (-0.37), ABBV: 65.71 (-0.28), PTIE: 2.22 (+0.02)

Bionomics Begins Trading on OTCQX Marketplace
PR Newswire - Mon Mar 02, 7:00AM CST
Bionomics Limited (ASX: BNO, OTCQX: BNOEF) today announced its ordinary shares commenced trading on the OTCQX marketplace in the U.S., effective March 2, 2015.

OTC Markets Group Welcomes Bionomics to OTCQX®
PR Newswire - Mon Mar 02, 6:00AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Bionomics Ltd. (ASX: BNO; OTCQX: BNOEF), a global biopharmaceutical company developing better treatments for cancer and central nervous system disorders, has qualified to trade on OTCQX®, the best marketplace for established, global and growth companies.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AprilAire Ups the Game in Home Air Quality Filters

Updated Category News Views 8

Taking Indoor Air Quality to New Heights with AprilAire Ever stepped inside a home and thought, “It just feels fresher in here”? Well, AprilAire's new TriPure™ Technology might be the reason why from now on. They've rolled out their new line of high-performance air filters, and they want to have a word about your indoor air quality. As folks get more serious about...

Continue Reading
Volvo Faces Rough Q3, Plans Strategic Responses

Updated Category News Views 1

Volvo's Bumpy Ride Through Q3 2026 Volvo Cars isn't painting a pretty picture for the third quarter of 2026. Posting an operating income of SEK -3.7 billion and a negative EBIT margin sitting at -5.6%, they're definitely feeling the heat. Market shifts in China and the U.S. are squeezing them, and it shows. Crunching the Numbers Let's break this down. Revenue nose-dived...

Continue Reading
ANCEL's Super Starter Impresses with Performance Boost

Updated Category News Views 1

More Than a Quick Fix: ANCEL's Impact Ever been frustrated because your car just won't start? Happens to the best of us, especially when that cold snap hits or your vehicle's been lounging around too long. ANCEL's Super Starter devices—let's talk about 'em. They've been making a name for themselves in the starting game, and I'm not yanking your chain here. According to...

Continue Reading
Navigating Car Accidents in Connecticut: Essential Steps

Updated Category News Views 2

Understanding the Immediate Chaos Post-Accident Alright, picture this: you've just been in a car accident in Connecticut. Your heart's pounding, and the scene's full of chaos. But here's the kicker - the actions you take now are crucial. It's easy to focus on the crumpled metal of your vehicle, but there's more at stake here. The decisions you make in these moments can...

Continue Reading
Unicycive's Stock Plunge: Fraud Suit and FDA Hurdles

Updated Category News Views 4

Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...

Continue Reading
CobbleStone & Chu Chua Tech: A Transformative Alliance

Updated Category News Views 3

Breaking Down the CobbleStone and Chu Chua Collaboration We’re in a tough, interconnected world where tech innovation is racing against the clock. So, when CobbleStone Software raises its hand to join forces with Chu Chua Technology Services LLP, it’s like a shot of adrenaline for anyone invested in North America’s tech wave. Let’s pause and dive right in because...

Continue Reading
Gen Z's Protein Cravings Drive Grocery Innovation

Updated Category News Views 6

Reser's Response to a Protein-Packed Demand Some days it feels like this younger generation is rewriting the food playbook. Gen Z, they’re prioritizing protein as if it’s the new gold, but they’re not exactly jumping on the typical offerings like shakes or yet another grilled chicken breast. This uptick in protein munchers has pushed Reser’s Fine Foods—known for...

Continue Reading
PKGD Group's Agave Spirits Surge 56% in 2026 Growth'

Updated Category News Views 6

PKGD Group's Impressive Growth Story Sometimes you read a report and it genuinely knocks the wind out of you—not because it’s unusual, but because it’s rare to see such robust numbers in a market that ain't exactly all sunshine and rainbows. PKGD Group, the brain behind some damn fine agave spirits, decided to take no prisoners this year, reporting a jaw-dropping...

Continue Reading
Qingdao's Food Trade Triumph at SIAL Paris Booms

Updated Category News Views 1

Qingdao Impresses in the Global Food Arena Well, 2026 is serving up something special from Qingdao. During SIAL Paris, everyone's talking about how Qingdao’s food companies smashed expectations with 82 million yuan in intended orders. You’ve got CCPIT Qingdao pulling the strings, setting up an exhibition platform that was nothing short of top-tier. Staging a Show at...

Continue Reading
Sunlife's Q3 2026 Results: Market Awaits Key Insights

Updated Category News Views 2

Sunlife Prepares to Unveil Third Quarter Performance Alright, folks, we're spinning the wheel again and betting on Sun Life Financial's (TSX: SLF) third quarter earnings, taking the spotlight on November 4, 2026. Anyone eyeballing this should circle their calendars, tie their shoelaces, and get prepared. Since they're laying out the details after the markets shut, looks...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Perú Mucho Gusto Culinary Festival Heads to NYC

Updated Category News Views 752

Perú Mucho Gusto Culinary Festival Makes NYC Debut The much-anticipated culinary festival known as the Perú Mucho Gusto is set to make its debut in the bustling city of New York, marking its first-ever North American edition. This vibrant celebration will take place over three enthralling days, allowing attendees to immerse themselves in the rich tapestry of Peruvian...

Continue Reading
European Markets Thrive as FTSE 100 Reaches New Heights

Updated Category News Views 148

European Markets Surge on Trade Deal Optimism Recently, European stocks experienced a significant rise, largely influenced by the positive sentiment around trade deals. Automobiles led the charge, notably with firms like Mercedes-Benz and Volkswagen seeing substantial gains. As trade discussions between the U.S. and Europe heat up, investors are optimistic about potential...

Continue Reading
Mon Courtier Energie Groupe Expands Operations to Belgium

Updated Category News Views 163

Mon Courtier Energie Groupe Launches Operations in Belgium Mon Courtier Energie Groupe (ISIN code: FR001400H3A0 - Ticker: ALMCE), a leading energy brokerage firm for businesses, is thrilled to announce its new operations in Belgium. This significant step underscores the company’s dedication to helping local businesses manage their energy costs more effectively. A New...

Continue Reading
Luda Technology Group Limited Reveals Full-Year Financial Performance

Updated Category News Views 147

Luda Technology Group Limited Reveals Annual Financial Results Recently, Luda Technology Group Limited (NYSE: LUD), a prominent manufacturer and trader of stainless steel and carbon steel flanges and fittings, announced its annual financial results. The Company finalized and submitted its comprehensive annual report on Form 20-F for the fiscal year ending December 31,...

Continue Reading
Axcelis Technologies Prepares for Critical Earnings Announcement

Updated Category News Views 104

Axcelis Technologies: A Closer Look at the Upcoming Earnings Axcelis Technologies (NASDAQ: ACLS) is gearing up for its quarterly earnings report soon. With anticipation building, investors are focused on the potential results of this significant announcement. Expected Earnings Performance Market analysts are looking toward Axcelis Technologies to potentially report an...

Continue Reading